Week in Review: November 10–14

Funding for African science; microbiome studies may have contamination worries; mind-controlled gene expression; DNA record keeper

Written byJef Akst
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

FLICKR, NICOLAS RAYMONDAs governments around the world devote money and resources to the ongoing Ebola outbreak in Sierra Leone, Guinea, and Liberia, researchers wonder whether the epidemic will draw funds away from other research programs, or raise awareness and bring in greater funding for African science in general. Many, of course, hope for the latter. Timely responses to these diseases require “top quality scientists and top-quality infrastructure,” Ambrose Talisuna, senior research fellow at the Kemri-Wellcome Trust Research Programme in Kenya and head of malaria drug resistance surveillance for East Africa, told The Scientist. “[Donors and governments] should fund these institutions; not just for research but to train quality scientists in Africa.”

FLICKR, CIMMYTLow-level contamination of bacterial DNA is widespread in common DNA extraction kits, according to a study published this week (November 11) in BMC Biology. Any number of contaminating taxa can overpower the true microbial composition of the sample, if starting concentrations are low, the researchers found. “The assumption has been they are sterile,” coauthor Alan Walker of the University of Aberdeen told The Scientist. “What [researchers] need to do is go back and do some negative controls and with a bit of confidence say, ‘they really are in the samples,’ in cases where maybe there are potentially suspicious results.”

WIKIPEDIA, RAMAEEG readings from a sensor fixed to human participants’ foreheads can be translated into signals that trigger gene expression in cells implanted beneath mice’s skin. The electrical energy of a person’s thoughts triggered an infrared LED diode to activate light-inducible genes in the implant. In response to the EEG signal, a surface transmitted the signal to a receiver that powered the infrared LED diode, prompting the genes within the implanted cells to be transcribed and translated into proteins that entered the mouse’s circulation. The technique was described this week (November 11) in Nature Communications.

“It sounds so futuristic and almost mad-scientist-like, but there might be diseases we could control . . . depending on the state of an individual’s mind,” said synthetic biologist Matthew Bennett of Rice University in Texas who was not involved with the study.

MOJTABA AMINResearchers this week (November 13) describe a new DNA editing system that can be triggered by exposure to chemicals or light. Called SCRIBE, for Synthetic Cellular Recorders Integrating Biological Events, the system targets specific DNA throughout the bacterial genome to mark when certain environmental events have taken place. The researchers, led by MIT’s Timothy Lu, published their work this week in Science.

“I think it’s pretty complicated, to some ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies